Amazon UK Chief Calls for Shift in Blame Over Youth Unemployment Points to Education Gaps Arkade Developers Reports Q4 Loss of Rs 10945 Crore Despite Revenue Growth UK Police Chiefs Propose AgeRestriction on Unsafe Social Media Platforms for Under16s US Prioritizes Integration of American AI Technologies in Asia Following HighLevel Diplomatic Engagement SpaceXs Starlink Emerges as Core Growth Driver Ahead of Potential Nasdaq Listing Nvidia Earnings Call in Focus China Chip Restrictions and Political Commentary Could Sway Markets OSS Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally MT Q1 2026 Earnings Modest EPS Beat Amidst Stable Steel Demand InflaRx NV IFRX Q4 2025 Earnings Narrower Loss and Pipeline Progress Lift Sentiment EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Rally REAX Q1 2026 Earnings NarrowerThanExpected Loss Fails to Move Shares Cactus Inc WHD Q1 2026 Earnings EPS Beat Fails to Boost Sentiment as Shares Slip LiqTech International LIQT Edges Lower as Resistance Level Holds Firm Arqit Quantum Inc Warrants ARQQW Slip Further Testing Critical Floor at 007 Piper Sandler PIPR Declines 101 as Stock Hovers Near Support Testing Recent Lows Invest Green Acquisition Rights IGACR Holds Steady at 015 in Quiet Trading DMO Edges Higher Western Asset Mortgage Opportunity Fund Shows Modest Gains Prediction Market Investments Surge Despite Regulatory Uncertainty Key Insights from Corporate Earnings Calls Auburn National Bancorporation Inc AUBN Q1 2026 Earnings Solid EPS Performance Amid Cautious Banking Environment International Paper IP Gains Momentum as Price Approaches Key Resistance APRE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 215 BKKT Q1 2026 Earnings Wide EPS Miss Disappoints Revenue Data Withheld CNS Q1 2026 Earnings EPS Misses Estimates Stock Declines CMBT Q1 2026 Earnings Massive EPS Surprise of 432 Driven by Strong Operational Performance IQST Q4 2025 Earnings Massive EPS Miss Highlights Ongoing Challenges Hooker Furnishings HOFT Q1 2026 Earnings EPS Misses Estimates Stock Gains on Resilient Demand MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline